McKesson HIPAA, Supply Chain Risk & Vendor Assessment

ThirdProof's investigation assigned McKesson a High Risk (Tier 2) rating with 90% confidence. The elevated risk rating reflects infrastructure exposure findings and supply chain transparency gaps — not sanctions or adverse media concerns. McKesson's scale as a Fortune 8 company and pharmaceutical distributor creates a large attack surface. Organizations should review the full investigation report for specific infrastructure findings and assess compensating controls.

As a pharmaceutical distributor and healthcare IT provider processing PHI, McKesson is subject to HIPAA requirements. Organizations evaluating McKesson should request a Business Associate Agreement (BAA) and verify HIPAA compliance documentation for the specific McKesson products and services in use. ThirdProof's investigation evaluates McKesson's security posture across 24 intelligence sources as part of HIPAA vendor due diligence.

Organizations should request McKesson's current SOC 2 Type II report directly. Given McKesson's diverse product portfolio spanning pharmaceutical distribution and healthcare IT, verify that the SOC 2 scope covers the specific McKesson services your organization uses. SOC 2 reports are confidential and cannot be independently verified through a public registry.

McKesson is a healthcare IT vendor that handles protected health information (PHI). Safety depends on their current security posture, certification status, and how they handle your specific data. ThirdProof automates this evaluation across 24 intelligence sources — sanctions databases (OFAC, EU, UN), business registration verification, adverse media scanning, and cyber risk assessment — producing a deterministic risk tier with confidence score. Run a free investigation to see McKesson's full risk profile.

SOC 2 certification is a critical compliance requirement for healthcare IT vendors like McKesson. ThirdProof scans the vendor's trust page and security documentation for certification claims, then cross-references those claims against independent registries where available. Certifications are classified as independently verified, vendor attested, or not found in evidence — ensuring you know the verification level of each claim.

FedRAMP authorization is relevant for government contractors evaluating healthcare IT platforms. Based on ThirdProof's investigation, McKesson is not currently listed on the FedRAMP Marketplace. Organizations with federal compliance requirements should verify this directly and consider alternative vendors with FedRAMP authorization where required.

Data breach history is an important signal for any vendor, particularly healthcare IT platforms like McKesson that handle protected health information (PHI). ThirdProof's adverse media analysis searches multiple news APIs and public records for data breaches, security incidents, lawsuits, regulatory enforcement actions, and financial distress signals. Each finding is linked to its original source with severity classification.

Sanctions screening is standard due diligence for healthcare IT vendors. ThirdProof screens McKesson against OFAC SDN, consolidated international sanctions lists, and PEP databases. The screening uses entity name verification to reduce false positives. If McKesson or any associated officers appear on a sanctions list, this triggers automatic escalation to the highest risk tier.

Assessing McKesson as a healthcare IT vendor involves verifying HIPAA, SOC 2, and HITRUST compliance, reviewing their subprocessor chain, and checking sanctions exposure. ThirdProof automates this across 24 intelligence sources in under 2 minutes — no questionnaires or vendor participation required. Your first 3 investigations are free.